Loading clinical trials...
Loading clinical trials...
China Observational Study of Smoking Cessation Patterns in Patients Undergoing Lung Surgery (CHAMPION Study)
The purpose of this study is to assess the current smoking status and smoking cessation attempts among smokers or recent smoking quitters during the perioperative period, to describe postoperative pulmonary complications (PPCs) and other postoperative complications (PCs) following a lung surgery, and to describe the smoking cessation methods and services patients received from their health care professionals (HCPs) and participant's satisfaction among participants with lung cancer, chronic obstructive pulmonary disorder (COPD), a pulmonary lesion (example, nodule, or ground glass opacity) or other pulmonary conditions who are admitted to the thoracic surgical unit of the participating hospitals in China.
Age
40 - 80 years
Sex
ALL
Healthy Volunteers
No
Xuanwu Hospital ,Capital Medical University
Beijing, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Ruijin Hospital Shanghai Jiao Tong University
Shanghai, China
Start Date
May 6, 2020
Primary Completion Date
December 9, 2021
Completion Date
December 9, 2021
Last Updated
April 27, 2025
290
ACTUAL participants
No intervention
OTHER
Lead Sponsor
Johnson & Johnson (China) Investment Ltd.
NCT07143110
NCT06885697
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04577599